Robert L. Zerbe M.D., Director at Vericel Corp (VCEL), sold 6,556 shares at $51.57 ($338K) on 2024-03-27, disclosed to the SEC on 2024-03-29.
Scheduled sale ($338k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.57 | 3,278 | $169K | 50.0% |
| 2 | $51.57 | 3,278 | $169K | 50.0% |
| Total | $51.57 avg | 6,556 | $338K | 100% |
| Filing → |
| VCEL | SELL | 2024-11-13 | $281K | — | Filing → |
| VCEL | SELL | 2024-02-22 | $36K | — | Filing → |
| VCEL | SELL | 2024-01-30 | $102K | — | Filing → |